Zivo Bioscience Inc (ZIVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,542 | 159 | 3 | 139 | 274 |
| Receivables | 2 | 28 | N/A | 4 | 4 |
| TOTAL | $1,635 | $437 | $495 | $711 | $425 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 8 | 59 | 81 | 106 | 130 |
| TOTAL | $8 | $59 | $81 | $106 | $130 |
| Total Assets | $1,643 | $496 | $576 | $816 | $556 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 742 | 1,279 | 1,700 | 1,617 | 1,406 |
| Accrued Expenses | 66 | 1,233 | 1,105 | 101 | 101 |
| Other current liabilities | N/A | 45 | 15 | N/A | N/A |
| TOTAL | $2,042 | $2,579 | $2,871 | $3,085 | $2,762 |
| Non-Current Liabilities | |||||
| Long Term Debt | 116 | N/A | N/A | N/A | N/A |
| TOTAL | $116 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,158 | $2,579 | $2,871 | $3,085 | $2,762 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,759 | 3,546 | 3,366 | 2,832 | 2,778 |
| Common Shares | 4 | 4 | 3 | 3 | 2 |
| Retained earnings | -136,967 | -135,365 | -133,097 | -124,860 | -123,582 |
| TOTAL | $-515 | $-2,083 | $-2,296 | $-2,269 | $-2,206 |
| Total Liabilities And Equity | $1,643 | $496 | $576 | $816 | $556 |